The need to expand expertise in cancer genetics beyond highly specialized genetics clinics is increasingly being recognized. In response, this practical book provides oncologists, specialist nurses, genetic counsellors, family doctors, and geneticists with comprehensive and easy-to-use guidelines on risk assessment and appropriate management. The book focuses on common familial cancers such as breast, colorectal, ovary, prostate and melanoma, and separate chapters cover cancer predisposing syndromes such as neurofibromatosis, familial adenomatous polyposis and their management.Includes bibliographical references and index.How to evaluate a family history / Bronwyn Kerr -- Guidelines for referral in Europe / Fred H. Menko -- Guidelines for g...
Genetic screening of the BRCA1/2 genes is performed to members of families with early onset breast a...
The identification of genes that place individuals at high risk of breast, ovarian, and colorectal c...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes th...
The recognition of an inherited component to breast cancer has led to an increase in demand for info...
The diagnosis of inherited cancer-susceptibility syndromes can enable identifi cation of individuals...
Background. Assessing a genetic risk for developing breast cancer is not an easy task for a GP. Curr...
Background. Assessing a genetic risk for developing breast cancer is not an easy task for a GP. Curr...
Two of the most common cancers are breast cancer and colorectal cancer. Up to 10% of cases of each a...
Breast cancer accounts for one third of all female cancer cases worldwide. A hereditary component ac...
A variable proportion of cancers have a genetic aetiology but genes rarely act alone in shaping canc...
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus...
All cancers are genetic disorders, but not all genetic disorders are inherited. Most cancers are spo...
Introduction: This nationwide study assessed the impact of Lynch syndrome-related risk management gu...
CITATION: Scott, C. J., Schoeman, M. & Urban, M. F. 2019. Cancer genetics : an approach to suspected...
Genetic screening of the BRCA1/2 genes is performed to members of families with early onset breast a...
The identification of genes that place individuals at high risk of breast, ovarian, and colorectal c...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...
Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes th...
The recognition of an inherited component to breast cancer has led to an increase in demand for info...
The diagnosis of inherited cancer-susceptibility syndromes can enable identifi cation of individuals...
Background. Assessing a genetic risk for developing breast cancer is not an easy task for a GP. Curr...
Background. Assessing a genetic risk for developing breast cancer is not an easy task for a GP. Curr...
Two of the most common cancers are breast cancer and colorectal cancer. Up to 10% of cases of each a...
Breast cancer accounts for one third of all female cancer cases worldwide. A hereditary component ac...
A variable proportion of cancers have a genetic aetiology but genes rarely act alone in shaping canc...
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus...
All cancers are genetic disorders, but not all genetic disorders are inherited. Most cancers are spo...
Introduction: This nationwide study assessed the impact of Lynch syndrome-related risk management gu...
CITATION: Scott, C. J., Schoeman, M. & Urban, M. F. 2019. Cancer genetics : an approach to suspected...
Genetic screening of the BRCA1/2 genes is performed to members of families with early onset breast a...
The identification of genes that place individuals at high risk of breast, ovarian, and colorectal c...
Introduction: BRCA 1 or 2 mutation carriers have a 45-85% risk of developing breast cancer and a 39-...